Cargando…

Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics

INTRODUCTION: Kochiae Fructus has been widely used in Chinese Herbal medicine to treat various diseases. We report a rapid and eco-friendly approach for cerium oxide (CeO(2)) nanoparticles (NPs) synthesis using the extract of medicinally important plant “Kochiae Fructus”, and the synthesized NPs wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haibin, Wan, Lei, Li, Xiaoling, Zhang, Mu, Shakoor, Adnan, Li, Wenqiang, Zhang, Xueyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719686/
https://www.ncbi.nlm.nih.gov/pubmed/36474529
http://dx.doi.org/10.2147/IJN.S379689
_version_ 1784843380455374848
author Lu, Haibin
Wan, Lei
Li, Xiaoling
Zhang, Mu
Shakoor, Adnan
Li, Wenqiang
Zhang, Xueyang
author_facet Lu, Haibin
Wan, Lei
Li, Xiaoling
Zhang, Mu
Shakoor, Adnan
Li, Wenqiang
Zhang, Xueyang
author_sort Lu, Haibin
collection PubMed
description INTRODUCTION: Kochiae Fructus has been widely used in Chinese Herbal medicine to treat various diseases. We report a rapid and eco-friendly approach for cerium oxide (CeO(2)) nanoparticles (NPs) synthesis using the extract of medicinally important plant “Kochiae Fructus”, and the synthesized NPs were named KF-CeO(2) NPs. METHODS: Various spectroscopic approaches such as transmission electron microscope (TEM), powder X-ray diffraction (XRD), and energy-dispersive X-Ray (EDX) were used to characterize the KF-CeO(2) NPs effectively. The antibacterial and biofilm inhibition activity of KF-CeO(2) NPs against Gram-positive and Gram-negative multi-drug resistant (MDR) bacteria was determined using the serial dilution method and XTT assay. KF-CeO(2) NPs were assessed for anticancer activity against HeLa cancer cells using an MTT assay. Cytobiocompatibility was determined in two normal cell lines (3T3 and hMSC). RESULTS AND DISCUSSION: The average size of the KF-CeO(2) NPs was 11.3 ± 3.9 nm with spherical morphology. KF-CeO(2) NPs demonstrated a greater than 95% bactericidal efficacy against MDR microorganisms. In addition, KF-CeO(2) NPs strongly suppressed (more than 79%) the biofilms of MDR bacteria, indicating their potential for addressing antibiotic resistance issues. Compared to Kochiae Fructus extract and CH-CeO(2) NPs, they exhibited significant cytotoxic effects (35.60% cell viability) on HeLa cancer cells. In addition, the KF-CeO(2) NPs were shown to be highly biocompatible with hMSC and 3T3 cell lines (85.13% and 81.17% cell viability, respectively), suggesting that they may be employed in biological systems. CONCLUSION: These data indicate that KF-CeO(2) NPs synthesized using Kochiae Fructus extract are promising alternative treatments for MDR. In addition, this study will give the potential for the sustained development of biocompatible NPs with enhanced biological capabilities derived from vital pharmaceutical plants.
format Online
Article
Text
id pubmed-9719686
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97196862022-12-05 Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics Lu, Haibin Wan, Lei Li, Xiaoling Zhang, Mu Shakoor, Adnan Li, Wenqiang Zhang, Xueyang Int J Nanomedicine Original Research INTRODUCTION: Kochiae Fructus has been widely used in Chinese Herbal medicine to treat various diseases. We report a rapid and eco-friendly approach for cerium oxide (CeO(2)) nanoparticles (NPs) synthesis using the extract of medicinally important plant “Kochiae Fructus”, and the synthesized NPs were named KF-CeO(2) NPs. METHODS: Various spectroscopic approaches such as transmission electron microscope (TEM), powder X-ray diffraction (XRD), and energy-dispersive X-Ray (EDX) were used to characterize the KF-CeO(2) NPs effectively. The antibacterial and biofilm inhibition activity of KF-CeO(2) NPs against Gram-positive and Gram-negative multi-drug resistant (MDR) bacteria was determined using the serial dilution method and XTT assay. KF-CeO(2) NPs were assessed for anticancer activity against HeLa cancer cells using an MTT assay. Cytobiocompatibility was determined in two normal cell lines (3T3 and hMSC). RESULTS AND DISCUSSION: The average size of the KF-CeO(2) NPs was 11.3 ± 3.9 nm with spherical morphology. KF-CeO(2) NPs demonstrated a greater than 95% bactericidal efficacy against MDR microorganisms. In addition, KF-CeO(2) NPs strongly suppressed (more than 79%) the biofilms of MDR bacteria, indicating their potential for addressing antibiotic resistance issues. Compared to Kochiae Fructus extract and CH-CeO(2) NPs, they exhibited significant cytotoxic effects (35.60% cell viability) on HeLa cancer cells. In addition, the KF-CeO(2) NPs were shown to be highly biocompatible with hMSC and 3T3 cell lines (85.13% and 81.17% cell viability, respectively), suggesting that they may be employed in biological systems. CONCLUSION: These data indicate that KF-CeO(2) NPs synthesized using Kochiae Fructus extract are promising alternative treatments for MDR. In addition, this study will give the potential for the sustained development of biocompatible NPs with enhanced biological capabilities derived from vital pharmaceutical plants. Dove 2022-11-30 /pmc/articles/PMC9719686/ /pubmed/36474529 http://dx.doi.org/10.2147/IJN.S379689 Text en © 2022 Lu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lu, Haibin
Wan, Lei
Li, Xiaoling
Zhang, Mu
Shakoor, Adnan
Li, Wenqiang
Zhang, Xueyang
Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics
title Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics
title_full Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics
title_fullStr Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics
title_full_unstemmed Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics
title_short Combined Synthesis of Cerium Oxide Particles for Effective Anti-Bacterial and Anti-Cancer Nanotherapeutics
title_sort combined synthesis of cerium oxide particles for effective anti-bacterial and anti-cancer nanotherapeutics
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719686/
https://www.ncbi.nlm.nih.gov/pubmed/36474529
http://dx.doi.org/10.2147/IJN.S379689
work_keys_str_mv AT luhaibin combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics
AT wanlei combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics
AT lixiaoling combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics
AT zhangmu combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics
AT shakooradnan combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics
AT liwenqiang combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics
AT zhangxueyang combinedsynthesisofceriumoxideparticlesforeffectiveantibacterialandanticancernanotherapeutics